UAE becomes third country to approve Eli Lilly's GLP-1 pill Foundayo for type 2 diabetes

The UAE approved Eli Lilly's GLP-1 pill Foundayo for type 2 diabetes, making it the third country globally to approve the drug for this use.

Detected & updated continuously · Source: Nebula